Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)
Close on Nov 17, 2026Market cap $140.36MP/E –Yield –
Drugs Made In America Acquisition II total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Drugs Made In America Acquisition II's total debt was $450.00K at Jun 30, 2026.
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $450.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $450.00K | – |
See a number that looks wrong?